Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Distribution of minimum inhibitory concentration for ceftriaxone in Euro-GASP 2004-13
Gonococcal antimicrobial susceptibility surveillance in Europe 2013 - Overall percentage of resistant Neisseria gonorrhoeae by antimicrobial year Euro-GASP 2004-13
They are young, mostly female and their number is constantly growing: with nearly 344 000 notified cases in 2009 chlamydia is the most frequently reported sexually transmitted infection (STI) across Europe.
The factsheet provides concise key information on Crimean-Congo haemorrhagic fever for medical purposes. It is appropriate for use in both endemic and non-endemic areas. (Adaptable templates available)
When should a medical air evacuation of an Ebola patient be considered What are the risks both for the patient and the accompanying medical staff and airplane crew
On 24 July 2012, the Ministry of Health of Uganda reported an outbreak of Ebola hemorrhagic fever from Kibaale district, Midwestern Uganda. As of 7 August 2012, 60 suspected cases, including 16 deaths, have been reported in Uganda.
With more than 32 000 cases, gonorrhoea was the second most commonly reported sexually transmitted infection (STI) in Europe in 2010. As data from the ECDC report Gonococcal antimicrobial susceptibility surveillance in Europe 2010 illustrates, gonococci have become more resistant to common agents for treatment and show reduced susceptibility to newer antibiotics. “This indicates the risk that gonorrhoea may become an untreatable disease in the near future”, stresses ECDC Director Marc Sprenger.